Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8973
Corporate User License Price USD 375
Corporate User License Price INR 26918
Site License Price USD 250
Site License Price INR 17945
Request a Quote

Report Title

EpiVax, Inc.-Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

EpiVax, Inc.-Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

EpiVax, Inc.-Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

EpiVax, Inc.-Strategic SWOT Analysis Review



Executive Summary

EpiVax, Inc.-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-GlobalData's summarization of the company's business strategy.

SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

EpiVax, Inc. (EpiVax) is an immunology company which develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear sequences of amino acids which activate natural regulatory T cells. It is an immune-modulation power tool being developed for auto-immune, auto-inflammatory and allergic conditions. EpiVax' service portfolio includes, immune engineering, immunogenicity screening, vaccine design and redesign. It also provides lab services such as in vivo, in vitro and ex vivo immunogenicity screening services including cell-free HLA binding assays. EpiVax is headquartered in Providence, Rhode Island, the US.

EpiVax, Inc. Key Recent Developments

Jan 11, 2016: EpiVax spins out Aceno Biotherapeutics at JP Morgan/Biotech Showcase 2016

Jun 30, 2015: Designing the future at EpiVax

Jun 25, 2015: Exploring the Link between Polio Vaccination and Hand Foot Mouth Disease

Jun 09, 2015: USD 5.2 Million Department of Defense Grant Awarded to “Vaccine on Demand” Consortium

Jun 08, 2015: USD 5.2 Million Department of Defense Grant to Vaccine on Demand Consortium

Reasons To Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

EpiVax, Inc.-Key Facts 6

EpiVax, Inc.-Key Employees 7

EpiVax, Inc.-Key Employee Biographies 8

EpiVax, Inc.-Key Operational Employees 9

EpiVax, Inc.-Major Products and Services 10

EpiVax, Inc.-Pharmaceutical Pipeline Products Data 11

EpiVax, Inc., Pipeline Products by Therapy Area 11

EpiVax, Inc., Pipeline Products by Development Phase 12

EpiVax, Inc.-History 14

EpiVax, Inc.-Company Statement 18

EpiVax, Inc.-Locations And Subsidiaries 19

Head Office 19

Section 2-Company Analysis 20

EpiVax, Inc.-Business Description 20

EpiVax, Inc.-SWOT Analysis 21

SWOT Analysis-Overview 21

EpiVax, Inc.-Strengths 21

Strength-EpiMatrix 21

Strength-Service Portfolio 21

Strength-Research Grants 21

EpiVax, Inc.-Weaknesses 22

Weakness-Lack of Marketed Products 22

EpiVax, Inc.-Opportunities 23

Opportunity-Effective Treatment of Hemophilia 23

Opportunity-Market Potential: Influenza Diseases 23

Opportunity-Strategic Partnerships 23

EpiVax, Inc.-Threats 24

Threat-Competitive Pressures 24

Threat-Increased Regulation 24

Threat-Uncertain R&D Outcomes 24

EpiVax, Inc.-Key Competitors 25

Section 3-Company's Lifesciences Financial Deals and Alliances 26

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27

EpiVax, Inc., Recent Deals Summary 28

Section 4-Company's Recent Developments 29

Jan 11, 2016: EpiVax spins out Aceno Biotherapeutics at JP Morgan/Biotech Showcase 2016 29

Jun 30, 2015: Designing the future at EpiVax 30

Jun 25, 2015: Exploring the Link between Polio Vaccination and Hand Foot Mouth Disease 31

Jun 09, 2015: USD 5.2 Million Department of Defense Grant Awarded to “Vaccine on Demand” Consortium 32

Jun 08, 2015: USD 5.2 Million Department of Defense Grant to Vaccine on Demand Consortium 33

Section 5-Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

EpiVax, Inc., Pipeline Products by Therapy Area 11

EpiVax, Inc., Pipeline Products by Development Phase 12

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 27

List of Tables

EpiVax, Inc., Key Facts 6

EpiVax, Inc., Key Employees 7

EpiVax, Inc., Key Employee Biographies 8

EpiVax, Inc., Key Operational Employees 9

EpiVax, Inc., Major Products and Services 10

EpiVax, Inc., Number of Pipeline Products by Therapy Area 11

EpiVax, Inc., Number of Pipeline Products by Development Stage 12

EpiVax, Inc., Pipeline Products By Therapy Area and Development Phase 13

EpiVax, Inc., History 14

EpiVax, Inc., Key Competitors 25

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27

EpiVax, Inc., Recent Deals Summary 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

VBI Vaccines Inc.

MVP Laboratories, Inc.

BioFactura, Inc.

Altravax, Inc.

Advanced BioScience Laboratories, Inc.

EpiVax, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand